Trial intelligence / Profile preview

Recombinant human interferon alpha-1b for children with viral pneumonia

ChiCTR-TRC-12002270Phase 4Completed

Sponsor
Zhengzhou Children's Hospital
Start
Jan 2012
Modality
Cytokines & Interferons → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, open-label trial of recombinant human interferon alpha-1b in viral pneumonia (4 arms), sponsored by Zhengzhou Children's Hospital. Primary endpoint: Clinical cure rate. Started Jan 2012; status: completed.

02

Drugs

recombinant human interferon alpha-1b
03

Conditions

viral pneumonia

Beyond the preview

Go deeper on ChiCTR-TRC-12002270.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-12002270.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call